Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
10 | 73914036 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
Digestive System Diseases | 0.700 | 1.000 | 2 | 2015 | 2016 | ||||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Nervous System Diseases; Mental Disorders | 0.020 | 1.000 | 2 | 2006 | 2013 | ||||||
|
1.000 | 0.080 | 10 | 73913679 | missense variant | C/G;T | snv | 4.4E-05; 2.4E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.827 | 0.120 | 10 | 73909432 | intron variant | G/C;T | snv |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Digestive System Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
Neoplasms | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
|
0.763 | 0.320 | 10 | 73913343 | missense variant | T/C | snv | 0.75 | 0.81 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.080 | 10 | 73916706 | 3 prime UTR variant | C/T | snv | 0.51 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.080 | 10 | 73916706 | 3 prime UTR variant | C/T | snv | 0.51 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |